CURRICULUM VITAE - Stanford University School of Medicine
CURRICULUM VITAE - Stanford University School of Medicine
CURRICULUM VITAE - Stanford University School of Medicine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
65. Mbizvo MT, Latif AS, Machekano R, MaFarland R, Bassett MT, Ray S, Katzenstein D.<br />
HIV seroconversion among factory workers in Harare: who is getting newly infected ?<br />
Central African Journal <strong>of</strong> <strong>Medicine</strong>, 43: 135-9, 1997.<br />
66. Shafer RW, Eisen J, Merigan TC, Katzenstein DA. Sequence and drug susceptibility <strong>of</strong><br />
subtype C reverse transcriptase from human immunodeficiency virus type 1<br />
serconverters in Zimbabwe. Journal <strong>of</strong> Virology, 71: 5441-5448, 1997.<br />
67. McFarland W, Mvere D, Katzenstein D. Risk factors for prevalent and incident HIV<br />
infection among volunteer blood donors in Harare, Zimbabwe: implications for blood<br />
safety. AIDS, 11: S97-S102.<br />
68. Kundu SK, Katzenstein D, Valentine FT, Spino C, Effron B, Merigan TC. Effect <strong>of</strong><br />
therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA<br />
and Plasma RNA: Relationship to cellular immune responses. Journal <strong>of</strong> Acquired<br />
Immune Deficiency Syndromes and Human Retrovirology, 15: 269-74, 1997.<br />
69. Raboud JM, Montaner JSG, Rae S, Kahn J, Hammer SM, Katzenstein DA. Metaanalysis<br />
<strong>of</strong> five randomized controlled trails comparing continuation <strong>of</strong> zidovudine versus<br />
switching to didanosine inHIV-infected individuals. Antiviral Therapy, 2(4): 237-247,<br />
1997.<br />
70. McFarland W, Mvere D, Shamu R, Katzenstein D. Risk factors for HIV infection among<br />
first-time blood donors in Zimbabwe. Transfusion 38:279-284, 1998.<br />
71. Lenderking WR, Testa MA, Katzenstein D, Hammer S. Measuring quality <strong>of</strong> life in early<br />
HIV disease: the modular approach. Quality <strong>of</strong> Life Res, 6: 515-30, 1997.<br />
71. Montano MA, Novitky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent<br />
transciptional regulation among expanding human imunodeficiency virus type 1<br />
subtypes. Journal <strong>of</strong> Virology, 71: 8657-8665, 1997.<br />
72. Mason PR, Gwanzura L, Latif A, Marowa E, Ray S, Katzenstein DA. Antimicrobial<br />
resistance in gonococci isolated from patients and from commercial sex workers in<br />
Harare, Zimbabwe. International Journal <strong>of</strong> Antimicrobial Agents 1997; 9:175-179.<br />
73. Delwart EL, Mullins JI, Gupta P, Learn G, Holodniy M, Katzenstein D, Waler B, Singh<br />
MK. Human immundeficiency virus type 1 populations in blood and semen. Journal <strong>of</strong><br />
Virology, 72: 617-623,1998.<br />
74. Goulston C, McFarland W, Katzenstein DA. Human Immunodeficiency Virus Type 1<br />
RNA Shedding in the Female Genital Tract. Journal <strong>of</strong> Infectious Diseases, 177: 1100-<br />
1103, 1998.<br />
75. Roesel DJ, Gwanzura L, Mason PR, J<strong>of</strong>fe M, Katzenstein, DA. Polymerase chain<br />
reaction <strong>of</strong> Haemophilus ducreyi DNA. Sex Transm Inf., 74:63-65, 1998.<br />
76. Lathey JL, Hughes MD, Fiscus SA, Pi T, Jackson B, Rasheed S, Elbeik T, Reichman R,<br />
10